2007
DOI: 10.1111/j.1468-3083.2007.02230.x
|View full text |Cite
|
Sign up to set email alerts
|

Pustular psoriasis induced by infliximab

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
4
0

Year Published

2008
2008
2016
2016

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 8 publications
1
4
0
Order By: Relevance
“…More than one hundred cases were reported in a 2008 review, with fifty‐three percent of affected persons taking infliximab prior to their psoriatic flare (1). Similar eruptions have been noted in each of the three available forms of TNFα‐antagonists (1–5). No predilection for age, sex, race, or underlying disease has been determined (1,2).…”
Section: Discussionsupporting
confidence: 58%
See 1 more Smart Citation
“…More than one hundred cases were reported in a 2008 review, with fifty‐three percent of affected persons taking infliximab prior to their psoriatic flare (1). Similar eruptions have been noted in each of the three available forms of TNFα‐antagonists (1–5). No predilection for age, sex, race, or underlying disease has been determined (1,2).…”
Section: Discussionsupporting
confidence: 58%
“…In the majority of reported cases, cutaneous lesions are managed adequately with topical corticosteroids while continuing anti‐TNFα therapy (1,2,4). Some authors did report more recalcitrant incidents requiring cessation of the TNFα‐inhibitor (1).…”
Section: Discussionmentioning
confidence: 99%
“…There are no reports of infliximab use in GPPP but it has been used successfully for pustular psoriasis of von Zumbusch 3 . Paradoxically, it has also been reported to induce pustular psoriasis 7 . Whether infliximab would have been safe to use during gestation in this case is uncertain.…”
mentioning
confidence: 88%
“…[54] Worsening of psoriasis after infliximab Paradoxical activation of psoriasis, including pustular psoriasis and palmoplantar pustulosis, with infliximab treatment has been occasionally observed in adults and in children. [55][56][57][58][59][60] Mössner et al [57] reported 5 patients with chronic plaque-type psoriasis who developed palmoplantar pustulosis during or after discontinuation of infliximab therapy. In two of the five cases, manifestation of palmoplantar pustulosis was not accompanied by worsening of plaque-type psoriasis.…”
Section: Infliximab With Concomitant Methotrexatementioning
confidence: 99%